# Gauss Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gauss-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Menlo Park, US
- Website: www.gausssurgical.com
- Total disclosed funding: $71M
- Latest round: Series D (Oct 27, 2020)
- Investors on record: 19

## About

Gauss Surgical, Inc. specializes in innovative medical technology designed for surgical environments, particularly focusing on real-time monitoring of blood loss during surgeries.Founded in 2011 and headquartered in Menlo Park, US, Gauss Surgical, Inc. develops solutions for surgical care. The company has not reported any significant pivots in business strategy. Its founders include Mark Gonzalgo and Siddarth Satish, with Milton McColl serving as CEO. Gauss Surgical has successfully raised funds through several rounds, with the most recent being a Series D round in September 2021, where it raised USD 30.00 mn, leading to a current valuation of USD 94.80 mn. The latest round was led by The 4100 Group and involved investors such as Allumia Ventures and Delta Dental. In September 2021, Stryker Corporation acquired Gauss Surgical, Inc. for an undisclosed amount.Gauss Surgical develops innovative medical technology tailored for surgical settings, focusing primarily on real-time blood loss monitoring. Their flagship product, the Triton System, employs advanced imaging and artificial intelligence to provide surgeons and medical teams with accurate, immediate assessments of blood loss during procedures. This technology enhances clinical decision-making, aiming to improve patient outcomes through timely intervention. Their solutions are utilized in various healthcare facilities, including hospitals and surgical centers, primarily within the United States and expanding to international markets such as Europe and Asia. The company serves a diverse clientele, including surgeons and hospital administrators, all prioritizing patient safety and effective surgical practices.Gauss Surgical generates revenue through the sale of its medical devices and associated software solutions, emphasizing a direct business-to-business model. The company engages with hospitals and surgical centers, facilitating transactions involving the purchase or leasing of the Triton System alongside service agreements for ongoing support and software updates. Revenue is structured around product sales and recurring service contracts, fostering long-term partnerships with healthcare providers, thus reinforcing the company's commitment to enhancing surgical safety and efficacy.Gauss Surgical plans to leverage recent funding to enhance its product offerings and expand into new markets. The acquisition by Stryker Corporation in September 2021 will allow for accelerated development and deployment of the Triton technology. This initiative aims to increase the adoption of the Triton System in various surgical environments, enhancing operational efficiency. The company is also eyeing expansion into international markets, including Europe and Asia, with plans to penetrate these regions within the next few years.

## Funding rounds

- Series D, Oct 27, 2020, $30M — Polaris Partners, SBVA, Delta Dental, Allumia Ventures, Northwell Holdings, OSF HealthCare, The 4100 Group
- Series C, Oct 17, 2018, $20M — Polaris Partners, SBVA, Memorial Hermann Pension Plan, St. Luke's-Roosevelt Hospital Center Employees Retirement Plan, Orlando Health, Allumia Ventures, Northwell Holdings, OSF HealthCare, Spectrum Health Ventures, Rex Health Ventures
- Series B, Mar 17, 2016, $13M — Promus Ventures, Jump Capital, Lifeforce Ventures, LLC, Summation Health Ventures, Allumia Ventures, Stanford-StartX Fund
- Series A, Jul 30, 2015, $3.3M — Promus Ventures, Lifeforce Ventures, LLC, Summation Health Ventures
- Seed, Oct 30, 2014, $1.5M — Promus Ventures
- Seed, Sep 6, 2013, $3.1M — Stanford University, Promus Ventures, Taube Investment Partners
- Seed, Dec 31, 2011, $0.8M — Promus Ventures

## Investors

- Promus Ventures (https://capitalatlas.ai/funds/promus-ventures) — Seed, Series A, Series B
- Stanford University — Seed
- Taube Investment Partners — Seed
- Lifeforce Ventures, LLC — Series A, Series B
- Summation Health Ventures (https://capitalatlas.ai/funds/summation-health-ventures) — Series A, Series B
- Jump Capital (https://capitalatlas.ai/funds/jump-capital) — Series B
- Allumia Ventures (https://capitalatlas.ai/funds/allumia-ventures) — Series B, Series C, Series D
- Stanford-StartX Fund — Series B
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series C, Series D
- SBVA (https://capitalatlas.ai/funds/sbva) — Series C, Series D
- Memorial Hermann Pension Plan — Series C
- St. Luke's-Roosevelt Hospital Center Employees Retirement Plan — Series C
- Orlando Health — Series C
- Northwell Holdings (https://capitalatlas.ai/funds/northwell-holdings) — Series C, Series D
- OSF HealthCare — Series C, Series D
- Spectrum Health Ventures (https://capitalatlas.ai/funds/spectrum-health-ventures) — Series C
- Rex Health Ventures (https://capitalatlas.ai/funds/rex-health-ventures) — Series C
- Delta Dental — Series D
- The 4100 Group — Series D